These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37723579)

  • 1. Comparative analysis of methodologies for predicting overall survival in patients with non-small cell lung cancer based on the number and rate of resected positive lymph nodes: A study based on the SEER database for 2010 through 2019.
    Guo Q; Hu S; Wang S; Su L; Zhang W; Xu J; Wei Y
    Clin Respir J; 2023 Nov; 17(11):1145-1157. PubMed ID: 37723579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study.
    Yu Y; Zhang P; Yao R; Wang J; Wang P; Xue X; Xiao J; Wang Z
    Transl Lung Cancer Res; 2020 Aug; 9(4):1285-1301. PubMed ID: 32953505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of different lymph node staging systems for predicting overall survival of node-positive patients with renal cell carcinoma: a retrospective cohort study using the Surveillance, Epidemiology and End Results database.
    Zheng W; Jiang W; Wu Q; Chen J; Zhang Z; Yu S; Guo C
    BMJ Open; 2023 Apr; 13(4):e068044. PubMed ID: 37185648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer.
    Deng W; Xu T; Wang Y; Xu Y; Yang P; Gomez D; Liao Z
    Lung Cancer; 2018 Aug; 122():60-66. PubMed ID: 30032846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.
    Wang S; Yu Y; Xu W; Lv X; Zhang Y; Liu M
    BMC Cancer; 2021 Aug; 21(1):653. PubMed ID: 34344326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors.
    Jiang S; Zhao L; Xie C; Su H; Yan Y
    Front Endocrinol (Lausanne); 2020; 11():402. PubMed ID: 32733379
    [No Abstract]   [Full Text] [Related]  

  • 7. Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Western Tertiary Center.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Am J Clin Oncol; 2021 Jan; 44(1):1-9. PubMed ID: 33086233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer.
    Jonnalagadda S; Arcinega J; Smith C; Wisnivesky JP
    Cancer; 2011 Oct; 117(20):4724-31. PubMed ID: 21452193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
    Shang X; Liu J; Li Z; Lin J; Wang H
    BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of lymph node ratio in stage III non-small-cell lung cancer: A retrospective cohort study.
    Zhang X; Feng N; Wu B; Wei Y; Zhang W
    Medicine (Baltimore); 2023 Oct; 102(40):e35341. PubMed ID: 37800757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data.
    He C; Ni M; Liu J; Teng X; Ke L; Matsuura Y; Okuda K; Sakairi Y; Cheng J; Yu L; Lv W; Hu J
    Transl Lung Cancer Res; 2024 Mar; 13(3):573-586. PubMed ID: 38601448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.
    Zhou X; Wu C; Cheng Q
    Lung; 2020 Oct; 198(5):839-846. PubMed ID: 32683563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Different Lymph Node Staging Schemes for Predicting Survival Outcomes in Node-Positive Endometrioid Endometrial Cancer Patients.
    Yang XL; Huang N; Wang MM; Lai H; Wu DJ
    Front Med (Lausanne); 2021; 8():688535. PubMed ID: 34307415
    [No Abstract]   [Full Text] [Related]  

  • 14. The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis.
    Kai L; Zhoumiao C; Shaohua X; Zhao C; Zhijun L; Zhengfu H; Xiujun C
    J Cardiothorac Surg; 2021 Jan; 16(1):13. PubMed ID: 33468199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Proposal for Combination of Lymph Node Ratio and Anatomic Location of Involved Lymph Nodes for Nodal Classification in Non-Small Cell Lung Cancer.
    Ding X; Hui Z; Dai H; Fan C; Men Y; Ji W; Liang J; Lv J; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; Lu N; He J; Wang L
    J Thorac Oncol; 2016 Sep; 11(9):1565-73. PubMed ID: 27223457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
    Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
    World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
    Fan Y; Du Y; Sun W; Wang H
    Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconsidering N component of cancer staging for T1-2N0-2M0 small-cell lung cancer: a retrospective study based on multicenter cohort.
    Wu LL; Qiu LH; Chen X; Yu WJ; Li CW; Qian JY; Liang SH; Lin P; Long H; Zhang LJ; Li ZX; Li K; Jiang F; Ma GW; Xie D
    Respir Res; 2023 Jun; 24(1):168. PubMed ID: 37353782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.
    Wang CL; Li Y; Yue DS; Zhang LM; Zhang ZF; Sun BS
    World J Surg; 2012 Feb; 36(2):455-62. PubMed ID: 22187129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.